BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10766758)

  • 1. Molecular mechanism of calcium channel block by isradipine. Role of a drug-induced inactivated channel conformation.
    Berjukow S; Marksteiner R; Gapp F; Sinnegger MJ; Hering S
    J Biol Chem; 2000 Jul; 275(29):22114-20. PubMed ID: 10766758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voltage-dependent acceleration of Ca(v)1.2 channel current decay by (+)- and (-)-isradipine.
    Berjukow S; Hering S
    Br J Pharmacol; 2001 Aug; 133(7):959-66. PubMed ID: 11487504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two amino acid residues in the IIIS5 segment of L-type calcium channels differentially contribute to 1,4-dihydropyridine sensitivity.
    Mitterdorfer J; Wang Z; Sinnegger MJ; Hering S; Striessnig J; Grabner M; Glossmann H
    J Biol Chem; 1996 Nov; 271(48):30330-5. PubMed ID: 8939992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cav1.4alpha1 subunits can form slowly inactivating dihydropyridine-sensitive L-type Ca2+ channels lacking Ca2+-dependent inactivation.
    Koschak A; Reimer D; Walter D; Hoda JC; Heinzle T; Grabner M; Striessnig J
    J Neurosci; 2003 Jul; 23(14):6041-9. PubMed ID: 12853422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels.
    Grabner M; Wang Z; Hering S; Striessnig J; Glossmann H
    Neuron; 1996 Jan; 16(1):207-18. PubMed ID: 8562085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinctions in the molecular determinants of charged and neutral dihydropyridine block of L-type calcium channels.
    Lacinová L; An RH; Xia J; Ito H; Klugbauer N; Triggle D; Hofmann F; Kass RS
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1472-9. PubMed ID: 10336541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfer of the high affinity dihydropyridine sensitivity from L-type To non-L-type calcium channel.
    Ito H; Klugbauer N; Hofmann F
    Mol Pharmacol; 1997 Oct; 52(4):735-40. PubMed ID: 9380037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voltage-dependent calcium channels.
    Lacinová L
    Gen Physiol Biophys; 2005 Jun; 24 Suppl 1():1-78. PubMed ID: 16096350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subunit regulation of the neuronal alpha 1A Ca2+ channel expressed in Xenopus oocytes.
    De Waard M; Campbell KP
    J Physiol; 1995 Jun; 485 ( Pt 3)(Pt 3):619-34. PubMed ID: 7562605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isradipine interacts with the open state of the L-type calcium channel at high concentrations.
    Lacinová L; Hofmann F
    Recept Channels; 1998; 6(3):153-64. PubMed ID: 10100324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The IVS6 segment of the L-type calcium channel is critical for the action of dihydropyridines and phenylalkylamines.
    Schuster A; Lacinová L; Klugbauer N; Ito H; Birnbaumer L; Hofmann F
    EMBO J; 1996 May; 15(10):2365-70. PubMed ID: 8665843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genetic screen for dihydropyridine (DHP)-resistant worms reveals new residues required for DHP-blockage of mammalian calcium channels.
    Kwok TC; Hui K; Kostelecki W; Ricker N; Selman G; Feng ZP; Roy PJ
    PLoS Genet; 2008 May; 4(5):e1000067. PubMed ID: 18464914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967).
    Bezprozvanny I; Tsien RW
    Mol Pharmacol; 1995 Sep; 48(3):540-9. PubMed ID: 7565636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conserved Ca2+-antagonist-binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain.
    Huber I; Wappl E; Herzog A; Mitterdorfer J; Glossmann H; Langer T; Striessnig J
    Biochem J; 2000 May; 347 Pt 3(Pt 3):829-36. PubMed ID: 10769189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serine residue in the IIIS5-S6 linker of the L-type Ca2+ channel alpha 1C subunit is the critical determinant of the action of dihydropyridine Ca2+ channel agonists.
    Yamaguchi S; Okamura Y; Nagao T; Adachi-Akahane S
    J Biol Chem; 2000 Dec; 275(52):41504-11. PubMed ID: 11022040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. State-dependent inhibition of inactivation-deficient Ca(V)1.2 and Ca(V)2.3 channels by mibefradil.
    Bernatchez G; Sauvé R; Parent L
    J Membr Biol; 2001 Nov; 184(2):143-59. PubMed ID: 11719851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric interactions required for high-affinity binding of dihydropyridine antagonists to Ca(V)1.1 Channels are modulated by calcium in the pore.
    Peterson BZ; Catterall WA
    Mol Pharmacol; 2006 Aug; 70(2):667-75. PubMed ID: 16675661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular determinants of diltiazem block in domains IIIS6 and IVS6 of L-type Ca(2+) channels.
    Hockerman GH; Dilmac N; Scheuer T; Catterall WA
    Mol Pharmacol; 2000 Dec; 58(6):1264-70. PubMed ID: 11093762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A region in IVS5 of the human cardiac L-type calcium channel is required for the use-dependent block by phenylalkylamines and benzothiazepines.
    Motoike HK; Bodi I; Nakayama H; Schwartz A; Varadi G
    J Biol Chem; 1999 Apr; 274(14):9409-20. PubMed ID: 10092621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. alpha 1D (Cav1.3) subunits can form l-type Ca2+ channels activating at negative voltages.
    Koschak A; Reimer D; Huber I; Grabner M; Glossmann H; Engel J; Striessnig J
    J Biol Chem; 2001 Jun; 276(25):22100-6. PubMed ID: 11285265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.